CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,416 enrolled
Drug / intervention
Nicotine replacement therapy +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03603496
NCT03603496Phase 4Completed

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers

Massachusetts General Hospital·interventional·Posted Jul 27, 2018·Updated May 5, 2022

In Brief

A Phase 4 clinical trial evaluating Transitional Tobacco Care Management (TTCM), eReferral to State Tobacco Quitline (QL), and 1 other intervention for Smoking Cessation. Completed, enrolled 1,416 participants across 3 sites.

Detailed Summary

This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJul 27, 2018
Enrollment StartSep 1, 2018
Primary CompletionNov 17, 2020
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.9 years ago

Interventions

Transitional Tobacco Care Management (TTCM)behavioral

PTCM will provide sustained care after discharge by offering (1) 8 weeks of nicotine replacement therapy at no cost provided at hospital discharge and (2) up to 7 proactive contacts over 3 months delivered by automated IVR call, supplemented by text messaging and email (patient choice). At each contact the patient is offered a return call from the hospital-based tobacco coach who offer counseling, medication advice, and coordination of care with the patient's outpatient health care team.

eReferral to State Tobacco Quitline (QL)behavioral

Referral from hospital to the state Quitline will be made by the research team on behalf of each enrolled patient. Feedback from the Quitline will be included in the patient's medical chart.

Nicotine replacement therapydrug

Up to 8 weeks of nicotine replacement therapy provided at no cost to the patient.